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Results. There was a signiﬁcant reduction of tumor growth in irradiated bed compared to control series, keeping macroscopic
characteristics. The fundamental microscopic features were: (A) Growth causing neoplastic cell nests and masses. (B) Presence
of large areas of necrosis. (C) Large areas of hemorrhage. (D) Expansive and inﬁltrative growth between previous tissues,
including skeletal muscle, adipose and connective tissue, nerves and vascular structures. (E) Cytological features typical of
melanotic neoplasm (polygonal or ovoid cells, nuclei with nucleoli voluminous, cytoplasm with variable amount of melanin
pigment, frequent mitoses, typical and atypical growth in perivascular rosettes and foci of necrosis and hemorrhage. (F) Variable
amount of stromal melanophages and inﬂammatory elements, as well as presence of spindle cells of ﬁbroblastic–myoﬁbroblastic
appearance. In all groups revealed changes in the expression of immunoreactivity for CD34 in the spindle cells, so that ﬁbroblasts
CD34+ present in areas tissue away from the neoformation were sparse in the stroma peri and intratumoral, while in its, most
acquired myoﬁbroblastic phenotype, positive for -smooth muscle actin.
Conclusion. Slower growth in irradiated bed is not dependent on the numbers of activated ﬁbroblasts in the TME, because, there
are not signiﬁcant differences in the number of myoﬁbroblasts in irradiated and non-irradiated stroma tumor.
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Abstract. The association of thymoma, with myasthenia gravis, pure red cell aplasia and hypogammaglobulinemia (Good’s syn-
drome), has been described. We report a case of a 59 years old men who after a surgical resection of a thymoma had several
symptoms and study shower hypogammaglobulinemia. The forgotten association of thymoma and malignancies is of a great
clinical signiﬁcance. Evidence linking thymoma with other neoplasms is provided by the clinical literature. Thymoma is a tumor
most common in the anterior mediastinum. Associated entities, commonly called cos paratími syndromes. The most common
is the association with myasthenia gravis (15%). The association with aplasia pure red cell (APSR) is 5–10% and in immunode-
ﬁciency called Good syndrome (GS), about 5%. The OS was ﬁrst described by Dr. Robert Good in 1954, is characterized by hypo
very gammaglobulinemia and B lymphocytes and decreased nuidos aplasia and anemia in patients with thymoma.
Objective. Review the treatment of TSG doing a literature review in Medline, report of a case.
Method and results. A review of Medline, entering as keywords THYMOMA, GOOD SYNDROME, APLASTIC ANEMIA, analyzing
the types of treatments published. History oncology: male patient is 59 years old, with a history of morbid: acute bronchial
syndrome, which Hematology tracking by serial red aplasia requiring frequent transfusions, CT scan is where objective: great
mediastinal mass inﬁltrating behavior , occupying the right lateral side of the anterior and middle mediastinal. She underwent
right sternotomy. Resection of a large tumor in the anteriormediastinum. Immunohistochemistry: CKAE1: positive. CK/18 positive
diffuse neoplasia. CD3/(+), CD5 (+), CD20 (−) CD99 (−), TdT (+), Ki-67: (5%). AP: AB thymoma. We studied the case and decided
adjuvant external radiotherapy in tumor bed, with energy 6MeV and 3D art, receiving 45–1.8Gy fractionation per session with
good tolerance.
Conclusions. Thymoma is associated with a risk of developing malignancies extratímicas also debuting with paraneoplastic syn-
drome, myasthenia gravis, aplastic anemia radiotherapy combined with excision of the tumor, seems to be an effective and
well tolerated in this tumor type, offering local control with a total radiation dose well tolerated, as in the published protocols
literature.
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Background/objective. Some countries have published an overview of the national status regarding the management of interrup-
tions to radiotherapy treatments. The objective of this work is to describe this situation in our area.
Methods. In order to obtain a preliminary overview of the current status regarding the management of radiotherapy interruptions
in our area, a short questionnaire was sent to all GOCO radiotherapy departments (18 Radiation Oncology Departments in
Catalonia, Midi-Pyrénées and Languedoc-Roussillon).
Results. A comprehensive survey on management of radiotherapy interruptions in GOCO radiation oncology departments has
been conducted A total of 18 replies were received giving a response rate of 100%. The results of the survey are detailed in this
work.
Conclusion. This survey has allowed us to know how to handle interruptions in GOCO Radiation Oncology Departments.
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